anti-NPY/PYY antibody (Garvan Inst)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameanti-NPY/PYY antibody (Garvan Inst)
Drug Alias Nameanti-neuropeptide Y/peptide YY antibody (Garvan Inst)humanized 5E12 monoclonal antibody (Garvan Institute of Medical Research)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionNeuropeptide Y receptors antagonists
TargetsNeuropeptide Y receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGarvan Institute Of Medical Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGarvan Institute Of Medical Research
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A